Home > Healthcare & Medical Devices > Tubeless Insulin Pump Market

Tubeless Insulin Pump Market - By End-use (Homecare, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI2032
  • Published Date: Oct 2023
  • Report Format: PDF

 Tubeless Insulin Pump Market Size

Tubeless Insulin Pump Market size was valued at around USD 1.6 billion in 2022 and is projected to reach over USD 8.9 billion by 2032. The increasing prevalence of diabetes is a significant driver for the market.


Tubeless Insulin Pump Market

To understand key trends  
Download Free Sample

According to the International Diabetes Federation (IDF), in 2021, the global population having diabetes mellitus (DM) was estimated to be 463 million in 2019 and is going to increase to 700 million by 2045. The increasing number of diabetes cases around the globe can be attributable to factors such as genetics, aging population, and lifestyle among others. Moreover, the ongoing technological advancements along with incremental healthcare expenditure associated with diabetes are further contributing to the market progress.


Tubeless insulin pump refers to a medical device designed to help manage diabetes by delivering a continuous supply of insulin to a patient's body without the need for traditional insulin injections. Tubeless insulin pumps are designed to be worn directly on the body and do not have external tubing.


However, the high cost associated with advanced tubeless insulin pumps can cause a challenge and hinder market growth in the projected timeframe. For instance, the cost of an adult insulin delivery system ranges between USD 4,500 to USD 6,500 and may vary according to the technology and sensors used in these devices. The high cost of these devices may limit acceptance by the diabetic population, affecting manufacturers’ ability to invest in the technology. Thus, the aforementioned factors are anticipated to impede the market expansion.


COVID-19 Impact

The COVID-19 pandemic had a slightly negative impact on the growth of the tubeless insulin pump market in the initial quarter of 2020. However, the subsequent three quarters of the year experienced a positive impact, ultimately offsetting the initial negative effect and consequently contributing to positive market demand.  


Tubeless Insulin Pump Market Trends

Rising technological advancements in insulin delivery devices intended to improve the comfort, safety, and overall well-being of individuals suffering from diabetes that will spur business growth. Modern tubeless insulin pumps come equipped with unique features such as advanced algorithms, an integrated continuous glucose monitoring (CGM) system, and bluetooth connectivity among others. The integration of a continuous glucose monitoring system allows users to monitor their blood glucose levels continuously and provide more accurate insulin delivery adjustments in real time, reducing the risk of hypoglycemia and hyperglycemia.


  • Moreover, tubeless insulin pumps often come equipped with bluetooth technology, enabling wireless communication with smartphones, or dedicated handheld controllers. According to the World Health Organization, about 422 million people worldwide suffer from diabetes, and 1.5 million deaths are directly attributed to diabetes each year. The rising prevalence of diabetes and related ailments propels the demand for tubeless insulin pumps.
  • This increasing diseased population is resulting in the adoption of more advanced tubeless that help in maintaining optimal blood glucose levels. Market players are also emphasizing the development of more technologically advanced insulin pumps. These advancements improve the overall patient experience, making it easier for clinicians to provide individualized treatment.


Tubeless Insulin Pump Market Analysis

Tubeless Insulin Pump Market Share, By End-use, (2022)

To understand key market trends  
Download Free Sample

The homecare segment accounted for USD 1.2 billion in 2022 and is set to witness notable growth in the coming years. This significant share is majorly attributed to the surging adoption of tubeless insulin pumps in home care settings. The surged pressure to limit the heightened healthcare expenses concerning diabetes management, notable developments, and access of these easy-to-use diabetes care devices is anticipated to drive the market size.


  • Further, the emergence of user-friendly and easy-to-use devices is set to promote the adoption rate of insulin pumps in home care settings. The devices are connected with a smartphone through bluetooth connectivity and offer useful features & reminders to the users that promote its utility.
  • Additionally, the building community supports for diabetes care initiative offers support to diabetes patients and encourages people to opt for diabetes care at homecare settings, intending to limit the expenses. Similarly, the increased demand among the geriatric population for diabetes care services in home care settings is estimated to propel the segment trends.
  • As a result, the emergence of advanced products that deliver ease in use are projected to fuel the product adoption in home care settings, further accelerating the market share.


North America Tubeless Insulin Pump Market Size, 2020- 2032 (USD Million)

To understand key market trends  
Download Free Sample

The North America tubeless insulin pump market is projected to reach USD 5.5 billion by 2032. This significant market growth is majorly attributed to the facilitative reimbursement scenario, the high prevalence of diabetes, and the presence of major market players in the region.

  • This high prevalence of diabetes in the region has led to an incremental surge in the healthcare costs directly and indirectly associated with the condition. The strong presence of leading manufacturers focusing on securing approvals and insurance coverage for their products to enhance affordability will majorly drive regional market development.
  • Furthermore, the increasing healthcare expenditure on diabetes, high spending ability on disease management, and awareness regarding the advent of new technologies are expected to boost product adoption in North America. As a result, the aforementioned factors are expected to accelerate the market progression in the region.

Tubeless Insulin Pump Market Share

The tubeless insulin pump industry is consolidated in nature, with major companies competing to offer superior tubeless insulin pumps in this business space. Prominent players such as Insulet Corporation hold a significant company market share. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, Insulet Corporation announced the U.S. FDA approval of the Omnipod DASH Insulin Management System with a tubeless pump, bluetooth connectivity, and personal diabetes manager. This enables quick access to insulin therapy information to patients as well as professionals on their smartphones.

Some of the major market players operating in the tubeless insulin pump industry are:

  • Insulet Corporation
  • Roche
  • Medtrum Technologies
  • Terumo Corporation
  • Mannkind Corporation
  • Terumo Corporation

Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company expansion.

Tubeless Insulin Pump Industry News:

  • In March 2021, Roche and Diabeloop announced a partnership to launch an automated insulin delivery solution that will integrate Accu-Check insulin pump and Diabeloop’s monitoring system. This partnership is expected to offer comprehensive solutions to diabetes patients and assist in channelling market share.
  • In September 2020, Terumo Corporation announced CE Mark approval for its MEDISAFE WITH insulin pump system. This pump is developed and manufactured in Japan and is the only tubing-free patch pump available in the country. This regulatory approval helped the company to promote product sales in the European region.

 Tubeless insulin pump market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (Million) from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By End-use, 2018 - 2032 (USD Million)

  • Home care
  • Hospitals & clinics
  • Others  

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Australia
  • RoW


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The tubeless insulin pump industry was valued at around USD 1.6 billion in 2022 and is projected to reach over USD 8.9 billion by the end of 2032, owing to the increasing prevalence of diabetes.

The homecare segment accounted for USD 1.2 billion in 2022 and is set to witness notable growth in the coming years, attributed to the surging adoption of tubeless insulin pumps in home care settings as well as user-friendly and easy-to-use nature of these devices.

North America market was worth USD 974 million in 2022 and is projected to reach USD 5.5 billion by 2032, pertaining to the facilitative reimbursement scenario, the high prevalence of diabetes, and the presence of major players in the region.

Insulet Corporation, Roche, Medtrum Technologies, Terumo Corporation, Mannkind Corporation, and Terumo Corporation, among others.

Tubeless Insulin Pump Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 6
  • Tables & Figures: 70
  • Countries covered: 12
  • Pages: 100
 Download Free Sample